EuCARE-POSTCOVID Study: a multicentre cohort study on long-term post-COVID-19 manifestations.
Benedetta Varisco, Francesca Bai, Sara De Benedittis...
https://pubmed.ncbi.nlm.nih.gov/37833640/Actively Recruiting
Led by Euresist Network GEIE · Updated on 2025-09-19
2300
Participants Needed
7
Research Sites
N/A
Total Duration
Researchers are investigating the long-term effects of COVID-19 by studying patients who have recovered from the acute phase of the disease to understand the prevalence and possible predictors of post COVID-19 condition. This condition involves symptoms that persist or newly appear at least three months after the initial infection, lasting for two or more months without another explanation. The study aims to identify factors such as age, gender, disease severity, and viral variants that may influence these ongoing symptoms and related organ damage. The study includes patients who have recovered from mild to severe COVID-19, with data collected retrospectively from post COVID-19 outpatient clinics and prospectively through ongoing follow-up visits. Patients undergo routine blood tests and evaluations by infectious disease specialists and other relevant medical professionals such as pulmonologists, cardiologists, neurologists, and psychologists, depending on individual clinical needs. Participants will be monitored over an average of three years to assess the incidence and persistence of post COVID-19 condition, identify risk factors, and evaluate long-term damage to organs including lungs, heart, and nervous systems. The study will also examine the role of different viral variants and immune responses. Data collection involves clinical visits, laboratory tests, and specialist assessments to provide a comprehensive understanding of post COVID-19 outcomes.
CONDITIONS
Post COVID-19 Condition
F
FRANCESCA INCARDONA, DR
A
ANTONELLA D'ARMINIO MONFORTE, PROF
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Euresist Network GEIE
Lead Sponsor
ASST Santi Paolo e Carlo
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 years
Participants who have recovered from an acute COVID-19 episode are observed over time to assess the incidence, risk factors, and long-term outcomes of post COVID-19 condition, including potential organ damage and symptom persistence.
Regular visits at post COVID-19 outpatient clinics as needed
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Benedetta Varisco, Francesca Bai, Sara De Benedittis...
https://pubmed.ncbi.nlm.nih.gov/37833640/Euresist Network GEIE
Lead Sponsor
ASST Santi Paolo e Carlo
Collaborating Sponsor